GAA and glycogen storage disease II: Enzyme replacement therapy (ERT) is the only approved treatment for Pompe disease and has been available since the Food and Drug Administration (FDA) approved recombinant human acid alpha-glucosidase (rhGAA; alglucosidase alfa) in 2006.